Exploring the neurobiological mechanisms of ketamine, psychedelics, and other rapid antidepressants

Explore the archives below.

Rapid Antidepressants Journal Club – 2024 Spring Schedule
January 22, 2024

Conor Liston (Cornell University)

February 19, 2024

Eero Castrén (University of Helsinki)

March 18, 2024

Robert Malenka (Stanford University)

April 15, 2024

Rick Strassman (University of New Mexico)

May 20, 2024

Candace Lewis (Arizona State University)

Rapid Antidepressants Journal Club – 2023 Schedule
January 23, 2023

NOTE date

Victoria DeLeon (WashU Psychiatry)

“Ketamine and Nitrous Oxide for Acute Suicidality”

Papers to review:

February 27, 2023

Rescheduled from February 20

Charles Zorumski (WashU Psychiatry)

Topic: New initiative to fund antidepressants research at WashU through the Taylor Foundation

Below are two papers that have just come out that may be of interest to you.

March 20, 2023

Manoj Doss (Johns Hopkins University)

“Cinco Sins of Psychedelic Science”

April 17, 2023

Alex Kwan (Cornell University)

“Visualizing drug actions on dendrites: From ketamine to psilocybin”

May 15, 2023

Charles Conway (WashU Psychiatry)

“A Phase II trial of Nitrous Oxide for TRD”

June 26, 2023

NOTE date

Candace Lewis (Arizona State University)

“Harnessing the malleable epigenome in the pursuit of healing”

September 18, 2023

Joshua Siegel (WashU Psychiatry)

October 16, 2023

Lindsay Cameron (Stanford University)

November 20, 2023

John McCorvy (Medical College of Wisconsin)

December 18, 2023

Boris Heifets (Stanford University)

Rapid Antidepressants Journal Club – 2022 Summer/Fall Schedule

July 18, 2022

Amelia Christensen (Kepecs lab, WashU Neuroscience)

“Interactions between psychedelic agonism of 5ht2a receptors and dopamine dependent reinforcement learning”

August 15, 2022

NOTE 3:00p start time

Rick Reneau (Braver lab, WashU Psychological & Brain Sciences)

“Imaging the effect of ketamine on synaptic density (SV2A) in the living brain” Molecular Psychiatry (2022)

September 19, 2022

Oliver Krentzman (Kepecs lab, WashU Neuroscience)

“Oxytocin-dependent reopening of a social reward learning critical period with MDMA” (Nature 2019)

October 17, 2022

Peter Lambert (Mennerick lab, WashU Psychiatry)

“Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2” (Neuron 2022)

November 21, 2022

Joshua Siegel (Nicol lab, WashU Psychiatry)
Jonah Padawer-Curry (Bauer lab, WashU Radiology)

WiP: “Neural and neurovascular effects of 5-HT2A receptor modulation (psychedelic, non-psychedelic agonism, and antagonism)”